213 related articles for article (PubMed ID: 6679687)
21. [Lipoproteins in arteriosclerosis obliterans of the lower limbs].
Sznajderman M; Rymaszewski Z; Kancelarczyk WL; Kuczyńska K
Pol Arch Med Wewn; 1983 Sep; 70(3):125-30. PubMed ID: 6657491
[No Abstract] [Full Text] [Related]
22. [Work capacity of patients with arteriosclerosis obliterans of the arteries of the lower limbs].
Petrik EI
Vrach Delo; 1974 Dec; (12):39-40. PubMed ID: 4446526
[No Abstract] [Full Text] [Related]
23. [Effect of complex treatment on indicators of lipid metabolism in patients with arteriosclerosis obliterans].
Polous IuM; Loĭko IK; Kurko VS; Gribenko GP; Golomazov MF
Vrach Delo; 1986 Jun; (6):4-7. PubMed ID: 3750955
[No Abstract] [Full Text] [Related]
24. [Serum lipid levels in patients with arteriosclerosis obliterans of the legs during treatment with pentoxifylline].
Kuczyńska K; Zebrowski M; Kancelarczyk WL; Rymaszewski Z
Pol Tyg Lek; 1988 Aug; 43(34):1092-4. PubMed ID: 3075031
[No Abstract] [Full Text] [Related]
25. [Effect of a single dose of heparin on the fibrinolytic activity of plasma euglobulins and studies on blood coagulation in patients with obliterative arteriosclerosis of the lower extremities].
Cencora A
Folia Med Cracov; 1973; 15(2):207-27. PubMed ID: 4758953
[No Abstract] [Full Text] [Related]
26. [Reactive hyperemia test under plethysmographic control in the early diagnosis of arteriosclerosis obliterans of the lower limbs].
Mc Cook Martínez J; Aldama Figueroa A; Bidart Labourdette J
Angiologia; 1981; 33(3):123-8. PubMed ID: 7258725
[No Abstract] [Full Text] [Related]
27. [Clinico-immunological indicators in patients with arteriosclerosis obliterans of the lower limbs after administration of thymalin].
Khavinson VKh; Morozov VG; Fisanovich TI; Tolstova LG
Klin Med (Mosk); 1983 Jun; 61(6):38-43. PubMed ID: 6604194
[No Abstract] [Full Text] [Related]
28. [Importance of the evaluation of rest time in arteriosclerotic patients with claudication intermittens of the lower limbs].
Noce R; Bormida A; Berti-Riboli E
Ann Ital Chir; 1969; 45(1):135-41. PubMed ID: 5402460
[No Abstract] [Full Text] [Related]
29. [The dynamics of the lipid metabolic shifts during the naphthalan therapy of patients with arteriosclerosis obliterans of the vessels of the lower extremities].
Gulieva SA
Vopr Kurortol Fizioter Lech Fiz Kult; 1992; (3):61-3. PubMed ID: 1413616
[No Abstract] [Full Text] [Related]
30. [Thermography in arteriosclerosis obliterans of the lower limbs].
Dudaev VA; Diukov IV; Kobelev IuM; Rat'ko OI
Sov Med; 1985; (3):111-5. PubMed ID: 4023824
[No Abstract] [Full Text] [Related]
31. [Ankle jerk reflex time in obliterative arteriosclerosis of lower limbs].
Smulski H; Kociubowska A
Wiad Lek; 1975 Feb; 28(4):261-3. PubMed ID: 1114829
[No Abstract] [Full Text] [Related]
32. Fibrinolysis and kinin system activity of venous and arterial blood in patients suffering from arteriosclerosis obliterans.
Lukjan H; Bielawiec M; Korfel B
Bibl Anat; 1975; 13():297-8. PubMed ID: 1231761
[No Abstract] [Full Text] [Related]
33. [Carbohydrate metabolism disorders in patients with obliterative arterial diseases of the lower extremities].
Tsybul'skiĭ VE
Vestn Khir Im I I Grek; 1971 May; 106(5):54-7. PubMed ID: 5139684
[No Abstract] [Full Text] [Related]
34. [Phospolipids in various obliterating arterial diseases of the lower limbs].
Gevorkian IKh; Karagezian KG; Akhverdian RA; Ovakimian SS
Zh Eksp Klin Med; 1977; 17(5):79-84. PubMed ID: 607720
[No Abstract] [Full Text] [Related]
35. [Fibrinolysis activation and the kininogen system and prostaglandin activity in the blood of patients with arteriosclerosis].
Lukjan H; Bielawiec M; Bodzenta A
Acta Haematol Pol; 1980; 11(3):121-7. PubMed ID: 6905632
[No Abstract] [Full Text] [Related]
36. [Extra-anatomical bypass as a part of the treatment of arteriosclerosis obliterans of the lower limbs].
Jelnes R; Baekgaard N
Ugeskr Laeger; 1984 Feb; 146(8):580-2. PubMed ID: 6710639
[No Abstract] [Full Text] [Related]
37. [Nicotinyl in the treatment of arteriosclerosis obliterans of the lower limbs].
Grodzińska L; Basista M; Byrska-Danek A; Kostka-Trabka E
Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):879-81. PubMed ID: 6387654
[No Abstract] [Full Text] [Related]
38. [Epidemiological approach to arteriosclerosis obliterans of the lower limbs].
Jouve A; Avril P; Aubert M; Rouvier M
Coeur Med Interne; 1966 Jul; 5(3):325-36. PubMed ID: 5946263
[No Abstract] [Full Text] [Related]
39. [Behavior and meaning of beta-thromboglobulin in chronic obliterative arteriopathy of the lower extremities. Preliminary study].
Binaghi F; Valle E; Manconi E; Pitzus F
Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6204655
[No Abstract] [Full Text] [Related]
40. [Risk factors in myocardial infarction and peripheral obliterating arteriosclerosis of the lower limbs].
Bubanj D; Custović F; Rukavina V; Ivković T
Lijec Vjesn; 1972 Aug; 99(8):402-7. PubMed ID: 4657164
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
